Koninklijke Philips (PHG) Capital Expenditures (2009 - 2026)
Koninklijke Philips (PHG) posted quarterly Capital Expenditures of -$159.2 million for Q2 2026, down 123.3% year-over-year from $683.4 million in Q2 2025, and down 86.33% quarter-over-quarter from -$85.5 million in Q1 2026.
Koninklijke Philips (PHG) Capital Expenditures (2009 - 2026) Analysis & Trends
Koninklijke Philips' Capital Expenditures history runs 18 years deep, the most recent figure standing at -$159.2 million for Q2 2026.
- In Q2 2026, Capital Expenditures fell 123.3% year-over-year to -$159.2 million; the TTM figure through Jun 2026 stood at -$775.3 million (down 6.95% YoY), while the FY2025 annual figure was $313.1 million, down 7.56% from the prior year.
- Capital Expenditures for Q2 2026 stood at -$159.2 million, down from -$85.5 million in the prior quarter.
- The five-year high for Capital Expenditures was -$57.9 million in Q1 2025, with the low at -$596.1 million in Q4 2023.
- The 5-year median for Capital Expenditures is -$170.0 million (2024), against an average of -$202.3 million.
- The sharpest annual moves came in 2025 and 2026: Capital Expenditures jumped 58.09% in 2025, then slumped 123.3% in 2026.
- Koninklijke Philips' Capital Expenditures stood at -$453.0 million in 2022, then tumbled by 31.59% to -$596.1 million in 2023, then surged by 43.17% to -$338.7 million in 2024, then increased by 7.56% to -$313.1 million in 2025, then soared by 49.14% to -$159.2 million in 2026.
- Business Quant data shows PHG's Capital Expenditures at -$159.2 million in Q2 2026, -$85.5 million in Q1 2026, and -$313.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 202.00 Mn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 195.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 66.90 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 84.70 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 100.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | -74.39 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 54.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -159.24 Mn |
| Jun 30, 2026 | -159.24 Mn |
| Mar 31, 2026 | -85.46 Mn |
| Mar 31, 2026 | -85.46 Mn |
| Dec 31, 2025 | -313.13 Mn |
| Dec 31, 2025 | -313.13 Mn |
| Sep 30, 2025 | -217.44 Mn |
| Sep 30, 2025 | -217.44 Mn |
| Jun 30, 2025 | -71.31 Mn |
| Jun 30, 2025 | -71.31 Mn |
| Mar 31, 2025 | -57.85 Mn |
| Mar 31, 2025 | -57.85 Mn |
| Dec 31, 2024 | -338.74 Mn |
| Dec 31, 2024 | -338.74 Mn |
| Sep 30, 2024 | -256.98 Mn |
| Sep 30, 2024 | -256.98 Mn |
| Jun 30, 2024 | -170.15 Mn |
| Jun 30, 2024 | -170.15 Mn |
| Mar 31, 2024 | -89.08 Mn |
| Mar 31, 2024 | -89.08 Mn |